Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Neuropharmacology. 2016 Mar 3;107:40–48. doi: 10.1016/j.neuropharm.2016.02.036

Fig. 3.

Fig. 3

GABAA γ2 receptor subunit phosphorylation. Intraperitoneal injection of 25mg/kg 1-NA-PP1 decreased GABAA γ2-S(P)327 immunoreactivity compared with vehicle. Left panel shows representative western blots for anti GABAA γ2S(P)327 immunoreactivity (top) and total GABAA γ2 immunoreactivity (bottom) from the same vehicle (Veh)- and 1-NA-PP1 (1-NA)-treated samples. Right panel shows mean ± S.E.M. results from all animals. *P = 0.0175, t(8) = 2.98, two-tailed, unpaired t-test; n = 5 per group.